ALYSON DEMITRASZEK: Open Payments
NPI 1205562899 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $325 · 2025 $533
Food & beverage: $433Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $158 |
| Incyte Corporation | 3 | $66 |
| Celgene Corporation | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $54 |
| BeiGene USA, Inc. | 1 | $33 |
| AVYXA PHARMA, LLC | 1 | $32 |
| ABBVIE INC. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
Products named: RYBREVANT, REBLOZYL, Enhertu, Padcev, JAKAFI, BRUKINSA, LUTRATE DEPOT, ELAHERE.
Industry payments across NY — which companies pay providers there.
